Lack of Any Role of Systemic Inflammatory Responses in Predicting Muscle Invasion by Bladder Cancer

  • Solakhan, Mehmet (Department of Urology, Medicalpark Gaziantep Hospital) ;
  • Demirpence, Ozlem (Department of Bioichemistry, Cumhuriyet University) ;
  • Orhan, Nuri (Department of Biochemistry, Medicalpark Gaziantep Hospital) ;
  • Yildirim, Omer Aydin (Department of Internal Medicine, Medicalpark Gaziantep Hospital) ;
  • Guzel, Ebru (Department of Radiology, Medicalpark Gaziantep Hospital) ;
  • Yildirim, Mustafa (Department of Medical Oncology, Medicalpark Gaziantep Hospital)
  • Published : 2016.08.01


Background: The purpose of this study is to evaluate if there is a relation between platelet: lymphocyte ratio (PLR) and neutrophil lymphocyte ratio (NLR) values and tumour histology and spread in bladder cancer cases. Materials and Methods: Bladder cancer patients undergoing TUR-M operation, with histopathologically verified diagnosis, followed-up and treated at the Private Medical Park Gaziantep Hospital between 2010 and 2015, have were included in the study. NLR and PLR values were calculated using complete blood count data obtained at the first presentation. Results: A total of 99 patients were included in the study, 7 (7.1%) women and 92 men (92.9%). When NLR was used as the indicator of systemic inflammatory response (SIR), it was determined that, 52 (52.5%) of the patients were SIR negative and 47 (47.5%) SIR positive. No significant relation could be detected between NLR and tumour grade and muscle invasion (p=0.948, p=0.480). When PLR was used as SIR indicator, it was determined that 71 (71.7%) of the patients were found as negative and 28 (28.3%) as positive. No significant relation could be detected between PLR and tumour grade and muscle invasion (p=0.651, p=0.494). Conclusions: In our study we did not detected a relation between tumour histological behavior and PLR and NLR in bladder cancer. However, NLR and PLR are easily calculated, accessible, inexpensive and simple-to-use laboratory data from whole blood counts.


Neutrophil/lymphocyte ratio;platelet/lymphocyte ratio;bladder cancer;prognosis;muscle invasion


  1. Atzpodien J, Royston P, Wandert T, et al (2003). Metastatic renal carcinoma comprehensive prognostic system. Br J Cancer, 88, 348-53.
  2. Aliustaoglu M, Bilici A, Ustaalioglu BB, et al (2010). The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment. Med Oncol, 27, 1060-5.
  3. Bambace NM, Holmes CE (2011). The platelet contribution to cancer progression. J Thromb Haemost, 9, 237-49.
  4. Babjuk M, Burger M, Zigeuner R, et al (2013). EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol, 64, 39-53.
  5. Ertas IE, Gungorduk K, Akman L, et al (2013). Can preoperative neutrophil: lymphocyte and platelet: lymphocyte ratios be used as predictive markers for lymph node metastasis in squamous cell carcinoma of the vulva? Eur J Obstet Gynecol Reprod Biol, 171, 138-42.
  6. Forrest LM, McMillan DC, McArdle CS, et al (2003). Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable nonsmall- cell lung cancer. Br J Cancer, 89, 1028-30.
  7. Gunaldi M, Goksu S, Erdem D, et al (2015). Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: a multicenter study. Int J ClinExp Med, 8, 5937-42.
  8. Goh BK, Chok AY, Allen JC Jr, et al (2015). Blood neutrophilto- lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumours. Surg.
  9. Hussein MR, Ahmed RA (2005). Analysis of the mononuclear inflammatory cell infiltrates in the non-tumourigenic, pre-tumourigenic and tumourigenic keratinocytic hyperproliferative lesions of the skin. Cancer Biol Ther, 4, 819-21.
  10. Kim HS, Han KH, Chung HH, et al (2010). Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison. Eur J Surg Oncol, 36, 691-8.
  11. Kaya V, Yildirim M, Demirpence O, et al (2013). Prognostic significance of basic laboratory methods in non- small-celllung cancer. Asian Pac J Cancer Prev, 14, 5473-6.
  12. Lee SM, Russell A, Hellawell G (2015). Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma. Korean J Urol, 56, 749-55.
  13. Mano R, Baniel J, Shoshany O, et al (2015). Neutrophil-tolymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer. Urol Oncol, 33, 1-7.
  14. Pollard JW (2004). Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer, 4, 71-8.
  15. Schmidt H, Bastholt L, Geertsen P,et al (2005). Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br J Cancer, 93, 273-8.
  16. Sylvester RJ (2006). Natural history, recurrence, and progression in superficial bladder cancer. Scientific World J, 6, 2617-25.
  17. Shimada H, Takiguchi N, Kainuma O et al (2010). High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer, 13, 170-6.
  18. Siegel R, Ma J, Zou Z, Jemal A (2014). Cancer statistics. CA Cancer J Clin, 64, 9-29.
  19. Seah JA, Leibowitz-Amit R, Atenafu EG, et al (2015). Neutrophil-lymphocyte ratio and pathological response to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer. Clin Genitourin Cancer, 13, 229-33.
  20. Smith RA, Ghaneh P, Sutton R, et al (2008). Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio. J Gastrointest Surg, 12, 1422-8.
  21. Topcu HO, Guzel AI, Ozer I, et al (2014). Comparison of neutrophil/lymphocyte and platelet/ lymphocyte ratios for predicting malignant potential of suspicious ovarian masses in gynecology practice. Asian Pac J Cancer Prev, 15, 6239-41.
  22. Wiesner T, Bugl S, Mayer F, et al (2010). Differential changes in platelet VEGF, Tsp, CXCL12, and CXCL4 in patients with metastatic cancer. Clin Exp Metastasis, 27, 141-9.
  23. Xu AM, Huang L, Zhu L, Wei ZJ (2014). Significance of peripheral neutrophil-lymphocyte ratio among gastric cancer patients and construction of a treatment-predictive model: a study based on 1131 cases. Am J Cancer Res, 4,189-95.
  24. Yamanaka T, Matsumoto S, Teramukai S, et al (2007). The baseline ratio of neutrophils to lymphocytes with patient prognosis in advanced gastric cancer. Oncol, 73, 215-20.
  25. Zhou X, Du Y, Huang Z, et al (2014). Prognostic value of PLR in various cancers: a meta-analysis. PLoS One, 9, 101119.